Use of continuous veno-venous haemodiafiltration therapy in dabigatran overdose

Author： Chiew A. L.   Khamoudes D.   Chan B. S. H.  

Publisher： Informa Healthcare

ISSN： 1556-3650

Source： Clinical Toxicology, Vol.52, Iss.4, 2014-04, pp. : 283-287

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Influence of continuous veno–venous haemodiafiltration and continuous veno–venous haemofiltration on the pharmacokinetics of fluconazole

By Muhl E.   Martens T.   Iven H.   Rob P.   Bruch H.-P.  

European Journal of Clinical Pharmacology, Vol. 56, Iss. 9-10, 2000-12 ,pp. : 671-678

Springer Publishing Company

Access to resources Recommend Favorite

Continuous veno-venous hemodiafiltration alleviates multiple organ dysfunction syndrome in dogs

By Chen Jihong  

Immunopharmacology and Immunotoxicology, Vol. 34, Iss. 6, 2012-12 ,pp. : 1001-1009

Informa Healthcare

Access to resources Recommend Favorite

Dabigatran etexilate: a guide to its use in preventing venous thromboembolic events

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 25, Iss. 2, 2009-02 ,pp. : 5-7

Adis International

Access to resources Recommend Favorite

Dabigatran Etexilate: A Review of its Use for the Prevention of Venous Thromboembolism after Total Hip or Knee Replacement Surgery

By Burness Celeste B.   McKeage Kate  

Drugs, Vol. 72, Iss. 7, 2012-05 ,pp. : 963-986

Adis International

Access to resources Recommend Favorite

Dabigatran etexilate for venous thromboembolism: a safety evaluation

By Brown Richard   Lip Gregory YH   Gallego Pilar  

Expert Opinion on Drug Safety, Vol. 13, Iss. 5, 2014-05 ,pp. : 639-647

Informa Healthcare

Access to resources Recommend Favorite